Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Emerson

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
Diabetes, Obesity & Metabolism|February 23, 2019
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)Kirstine Brown-Frandsen, Scott S Emerson, Darren K McGuire, et al.
Journal of the American Chemical Society|March 19, 2026
La<sup>3+</sup> Networks and Speciation in the Molten State: Impact of Spacer Salt Selection on Structural HeterogeneityBichitra Borah, Matthew S Emerson, Santanu Roy, et al.
Diabetes, Obesity & Metabolism|April 13, 2026
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT TrialsDirk Müller-Wieland, Darren K McGuire, A Michael Lincoff, et al.
Archives of Gerontology and Geriatrics|May 27, 2014
Physical working capacity at fatigue threshold (PWCFT) is associated with sarcopenia-related body composition and measures of functionality in older adultsNadia S Emerson, David H Fukuda, Jeffrey R Stout, et al.
Diabetes, Obesity & Metabolism|March 10, 2019
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)Richard E Pratley, Scott S Emerson, Edward Franek, et al.
Diabetologia|September 16, 2017
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)Bernard Zinman, Steven P Marso, Neil R Poulter, et al.
The New England Journal of Medicine|June 13, 2017
Efficacy and Safety of Degludec versus Glargine in Type 2 DiabetesSteven P Marso, Darren K McGuire, Bernard Zinman, et al.
The Journal of Physical Chemistry. B|July 11, 2023
Structural Origins of Viscosity in Imidazolium and Pyrrolidinium Ionic Liquids Coupled with the NTf<sub>2</sub><sup>-</sup> AnionRaphael Ogbodo, Waruni V Karunaratne, Gobin Raj Acharya, et al.
The New England Journal of Medicine|October 5, 2012
The prevention and treatment of missing data in clinical trialsRoderick J Little, Ralph D'Agostino, Michael L Cohen, et al.
American Heart Journal|September 11, 2020
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and designDonna H Ryan, Ildiko Lingvay, Helen M Colhoun, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Diabetes, Obesity & Metabolism|February 23, 2019
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)Kirstine Brown-Frandsen, Scott S Emerson, Darren K McGuire, et al.
Journal of the American Chemical Society|March 19, 2026
La<sup>3+</sup> Networks and Speciation in the Molten State: Impact of Spacer Salt Selection on Structural HeterogeneityBichitra Borah, Matthew S Emerson, Santanu Roy, et al.
Diabetes, Obesity & Metabolism|April 13, 2026
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT TrialsDirk Müller-Wieland, Darren K McGuire, A Michael Lincoff, et al.
Archives of Gerontology and Geriatrics|May 27, 2014
Physical working capacity at fatigue threshold (PWCFT) is associated with sarcopenia-related body composition and measures of functionality in older adultsNadia S Emerson, David H Fukuda, Jeffrey R Stout, et al.
Diabetes, Obesity & Metabolism|March 10, 2019
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)Richard E Pratley, Scott S Emerson, Edward Franek, et al.
Diabetologia|September 16, 2017
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)Bernard Zinman, Steven P Marso, Neil R Poulter, et al.
The New England Journal of Medicine|June 13, 2017
Efficacy and Safety of Degludec versus Glargine in Type 2 DiabetesSteven P Marso, Darren K McGuire, Bernard Zinman, et al.
The Journal of Physical Chemistry. B|July 11, 2023
Structural Origins of Viscosity in Imidazolium and Pyrrolidinium Ionic Liquids Coupled with the NTf<sub>2</sub><sup>-</sup> AnionRaphael Ogbodo, Waruni V Karunaratne, Gobin Raj Acharya, et al.
The New England Journal of Medicine|October 5, 2012
The prevention and treatment of missing data in clinical trialsRoderick J Little, Ralph D'Agostino, Michael L Cohen, et al.
American Heart Journal|September 11, 2020
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and designDonna H Ryan, Ildiko Lingvay, Helen M Colhoun, et al.
Pageof 25